Journal Article |
| Rauenzahn SL, Schmidt S, Aduba IO, Jones JT, Ali N, Tenner LL. "Integrating Palliative Care Services in Ambulatory Oncology: An Application of the Edmonton Symptom Assessment System" Journal of Oncology Practice 2017 Feb;2017.
|
| Schmidt S, Goros M, Parsons HM, Saygin C, Wan HD, Shireman PK, Gelfond JA. Improving initiation and tracking of research projects at an Academic Health Center: A case study Eval Health Prof 2016 Sep;Epub.
|
| Parsons HM, Schmidt S, Tenner LL, Davidoff AJ
. Trends in Antineoplastic Receipt after Medicare Payment Reform: Implications for Future Oncology Payment Design Journal of Cancer Policy 2016 Sep;.
|
| Parsons HM, Schmidt S, Tenner LL, Bang H, Keegan THM. Early Impact of the Patient Protection and Affordable Care Act on Insurance Among Young Adults With Cancer: Analysis of the Dependent Insurance Provision Cancer 2016 Jun;122(11):1766-1773.
|
| Parsons H, Schmidt S, Karnad A, Liang Y, Pugh MJ, Fox E. Association between the number of suppliers for critical antineoplastics and drug shortages: Implications for future drug shortages and treatment Journal of Oncology Practice 2016 Mar;12(3):249-250.
|
| Parsons HM, Harlan LC, Schmidt S, Keegan THM, Lynch CF, Kent EE, Wu WC, Schwartz SM, Chu RL, Keel G, Smith AW. Who treats adolescents and young adults with cancer? A report from the AYA HOPE study Journal of Adolescent and Young Adult Oncology 2015 Sep;4(3):141-150.
|
| Bollinger MJ, Schmidt S, Pugh JA, Parsons HM, Copeland LA, Pugh MJ. Erosion of the healthy soldier effect in veterans of U.S. military service in Iraq and Afghanistan Population Health Metrics 2015 Mar;13(8):1-12.
|
| Parsons HM, Lathrop KI, Schmidt S, Mazo-Canola M, Trevino-Jones J, Speck H, Karnad AB. Breast cancer treatment delays in a majority minority community: is there a difference? J Oncol Pract 2015 Mar;11(2):144-153.
|
| Parsons HM, Schmidt S, Harlan LC, Kent EE, Lynch CF, Smith AW, Keegan TH and the AYA HOPE Collaborative. Young and uninsured: Insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study Cancer 2014 Aug;120(15):2352-2360.
|
| Schmidt S, Parsons HM. Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008-2012 National Health Interview Survey Am J Public Health 2014 May;104(5):946-953.
|
| Sparks PJ, Schmidt S. A Demographic Analysis of Metro/Nonmetro Differences in Adult Normal Weight, Overweight, and Obesity Journal of Rural Social Sciences 2012 Jan;27(3):46-73.
|
Federal |
| Funding Agency |
NCATS |
| Title |
Clinical and Translational Science Award: Institute for Integration of Medicine and Science: a Partnership to Improve Health |
| Status |
Active |
| Period |
7/2013 - 6/2018 |
| Role |
Contributor |
| Grant Detail |
Within the Institute for Integration of Medicine and Science, MJ Lichtenstein served as the Co-Principal Investigator for Research Education, Training, and Career Development.
NCATS - KL2 TR001118 - KL2 Scholars Career Development Award Program
Total Costs KL2: $3,274,065
NCATS - TL1 TR001119 - TL1 Pre-doctoral Training Program
Total Costs TL1: $620, 395
Dr. Lichtenstein stepped down from his IIMS responsibilities on 12.31.2015
Total Costs for UL1 + KL2 + TL1: $22,707,724
ABSTRACT: San Antonio, the gateway to South Texas, is the 7*^ largest city in the US and the largest metropolitan area with a majority Hispanic population (63%). South Texas is about the size of Ohio, and comprises an impoverished and largely Hispanic population with disproportionate rates of diabetes and obesity, exacerbated by a lack of health insurance and poor access to health care. This region also contains numerous US military installations, and active-duty service members and veterans often have special health issues, including risk for post-traumatic stress disorder and traumatic injuries. Unfortunately, neither better access to care nor improved care delivery can eliminate health disparities and meet these complex needs, in addition, research across the full T1 to T4 translational spectrum is required to eliminate knowledge gaps and establish real-world effectiveness that improves health care for our populations. In 2006, UTHSCSA established the Institute for Integration of Medicine and Science (IIMS) to improve health and reduce disparities by accelerating scientific discoveries and applications across the full translational research spectrum. For example, IIMS expanded the number of clinical research units that extend to the Texas-Mexico border from 1 to 7, and dramatically increasing participant access to clinical and translational science. We increased, from 2 to 6, the Practice-Based Research Networks that focus on diverse ambulatory populations. Efforts to address tr |
| Funding Agency |
National Center for Advancing Translational Sciences, National Institutes of Health |
| Title |
Institute for Integration of Medicine and Science Mentored Research Career Development Award (KL2 Scholar) |
| Status |
Active |
| Period |
5/2016 - 4/2018 |
| Role |
Principal Investigator |
| Grant Detail |
Alleviating disparities in breast cancer care and outcomes: The role of changing Medicare Disproportionate Share Hospitals payments in the light of healthcare reform |
| Funding Agency |
National Cancer Institute |
| Title |
The Impact of the Medicare Prescription Drug, Improvement and Modernization Act (MMA) on Reducing Cancer-Related Treatment Disparities and Outcomes |
| Status |
Complete |
| Period |
9/2013 - 5/2016 |
| Role |
Contributor |
| Grant Detail |
The aim of this career development award is to build a long-term research agenda focused on understanding how payment and policy changes for medical technologies influence treatment availability, patterns of care, healthcare utilization and outcomes for cancer. The objective of this research is to evaluate patterns in use and shortages of FDA-approved treatment regimens for the three most common cancers in the US (colon, breast and lung) and the resulting impact on health outcomes after the implementation of the MMA in the Medicare population. |
| Funding Agency |
National Center for Advancing Translational Sciences |
| Title |
Epidemiology of MRI-confirmed Late Effects in Anthracycline Exposed Survivors of Childhood Cancer |
| Status |
Complete |
| Period |
12/2013 - 11/2014 |
| Role |
Co-Investigator |
| Grant Detail |
The overall goal of this IIMS pilot grant is to use cardiac MRI to evaluate cardiac structure and function in 30 long-term survivors of pediatric cancer with a history of exposure to anthracyclines. Therefore, our specific aims are to 1) quantify the proportion and type of MRI-confirmed cardiac late effects among a sample of anthracycline exposed adult survivors of childhood cancer and compare to standard screening methods and 2) examine the association between anthracycline exposure and development of MRI-confirmed cardiac dysfunction. |
Private |
| Funding Agency |
St. Baldricks Foundation |
| Title |
Adolescent and Young Adult Survivorship Program Infrastructure Grant(Saint Baldrick`s Foundation Infrastructure Grant) (01/01/2014 - 06/01/2015) |
| Status |
Complete |
| Period |
1/2014 - 6/2015 |
| Role |
Co-Investigator |
| Grant Detail |
The goal of this project is to help build an Adolescent and Young Adult (AYA) Survivorship Program to ensure that more adolescents and young adults can be treated on clinical trials, and to provide survivorship planning. We are conduct focus groups and surveys among AYA cancer survivors to learn about their needs for such a survivorship program. |
|
| Funding Agency |
UTHSCSA SOM Clinical Investigator Kickstart Program (ClIK) |
| Title |
Outcomes of Young Adults with Cancer after Recent Health Policy Changes |
| Status |
Complete |
| Period |
7/2015 - 6/2016 |
| Role |
Co-Principal Investigator |
| Grant Detail |
The goal of this research is to examine changes in and continued barriers to health insurance coverage of recently diagnosed young adult cancer patients during the implementation of the Patient Protection and Affordable Care Act. This study utilizes a mixed methods approach consisting of quantitative analyses of large population-based cancer registry data and qualitative analysis of focus groups with cancer survivors. |
